+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "B Cell Lymphoma Drug"

B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 280 Pages
  • Global
From
Diffuse Large B-cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 - Product Thumbnail Image

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • Report
  • March 2018
  • 280 Pages
  • Global
From
Diffuse Large B-cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
B-Cell Lymphomas - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

B-Cell Lymphomas - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
B-Cell Lymphomas - Epidemiology Forecast to 2032 - Product Thumbnail Image

B-Cell Lymphomas - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Diffuse Large B-cell Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 - Product Thumbnail Image

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • Drug Pipelines
  • October 2018
  • 475 Pages
  • Global
From
Diffuse Large B Cell Lymphoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Diffuse Large B Cell Lymphoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 103 Pages
  • Global
From
Splenic Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Splenic Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 54 Pages
  • Global
From
Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 129 Pages
  • Global
From
Marginal Zone B-cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Marginal Zone B-cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 193 Pages
  • Global
From
Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 55 Pages
  • Global
From
Extranodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Extranodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 66 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator

The B Cell Lymphoma Drug market is a subset of the larger Lymphoma Drugs market. It is composed of drugs used to treat B Cell Lymphoma, a type of cancer that affects the B cells of the immune system. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the patient's quality of life. Commonly used drugs include monoclonal antibodies, chemotherapy, and targeted therapies. The B Cell Lymphoma Drug market is highly competitive, with many companies offering innovative treatments. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more